Back to Trades
Chimovits Erez
DirectorCIK 0001706399
Profile
- Filings
- 6
- Buy transactions
- 3
- Sell transactions
- 0
- Companies
- 3
- Active
- 2026
Chimovits Erez, Director, has filed 6 SEC reports (2026), spread across 3 companies, totaling $36.6M in disclosed volume. Weighing $36.0M bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $34.9M in Braveheart Bio, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Sep 30 | ADRX ADARx Pharmaceuticals, Inc. | Chimovits Erez | Director | Buy | $1.0M |
| Sep 24 | ADRX ADARx Pharmaceuticals, Inc. | Chimovits Erez | Insider | Other | $0 |
| Aug 11 | BRVE Braveheart Bio, Inc. | Chimovits Erez | Director, 10% Owner | Buy | $34.9M |
| Aug 7 | BRVE Braveheart Bio, Inc. | Chimovits Erez | Director, 10% Owner | Award | $540.0K |
| Aug 5 | BRVE Braveheart Bio, Inc. | Chimovits Erez | Director, 10% Owner | Other | $0 |
| Jun 11 | UPB Upstream Bio, Inc. | Chimovits Erez | Insider | Award | $114.4K |
6 filings